| Product Code: ETC11459631 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Bio Engineered Proteins Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Bio Engineered Proteins Drugs Market - Industry Life Cycle |
3.4 Thailand Bio Engineered Proteins Drugs Market - Porter's Five Forces |
3.5 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Thailand Bio Engineered Proteins Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Thailand, driving the demand for bio-engineered protein drugs. |
4.2.2 Government initiatives promoting research and development in the biotechnology sector. |
4.2.3 Growing investments by pharmaceutical companies in Thailand's bio-engineered protein drugs market. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for bio-engineered protein drugs in Thailand. |
4.3.2 High costs associated with research, development, and production of bio-engineered protein drugs. |
5 Thailand Bio Engineered Proteins Drugs Market Trends |
6 Thailand Bio Engineered Proteins Drugs Market, By Types |
6.1 Thailand Bio Engineered Proteins Drugs Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Recombinant Proteins, 2021 - 2031F |
6.1.4 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Vaccines, 2021 - 2031F |
6.2 Thailand Bio Engineered Proteins Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Chronic Diseases, 2021 - 2031F |
6.2.3 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Cancer Therapy, 2021 - 2031F |
6.2.4 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3 Thailand Bio Engineered Proteins Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Patients, 2021 - 2031F |
6.4 Thailand Bio Engineered Proteins Drugs Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Genetic Engineering, 2021 - 2031F |
6.4.3 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Bioprocessing, 2021 - 2031F |
6.4.4 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Protein Synthesis, 2021 - 2031F |
6.5 Thailand Bio Engineered Proteins Drugs Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Effective Treatment, 2021 - 2031F |
6.5.3 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.5.4 Thailand Bio Engineered Proteins Drugs Market Revenues & Volume, By Immunization, 2021 - 2031F |
7 Thailand Bio Engineered Proteins Drugs Market Import-Export Trade Statistics |
7.1 Thailand Bio Engineered Proteins Drugs Market Export to Major Countries |
7.2 Thailand Bio Engineered Proteins Drugs Market Imports from Major Countries |
8 Thailand Bio Engineered Proteins Drugs Market Key Performance Indicators |
8.1 Research and development expenditure in the biotechnology sector in Thailand. |
8.2 Number of patents filed for bio-engineered protein drugs in Thailand. |
8.3 Number of clinical trials conducted for bio-engineered protein drugs in Thailand. |
9 Thailand Bio Engineered Proteins Drugs Market - Opportunity Assessment |
9.1 Thailand Bio Engineered Proteins Drugs Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Thailand Bio Engineered Proteins Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand Bio Engineered Proteins Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Thailand Bio Engineered Proteins Drugs Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Thailand Bio Engineered Proteins Drugs Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 Thailand Bio Engineered Proteins Drugs Market - Competitive Landscape |
10.1 Thailand Bio Engineered Proteins Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Bio Engineered Proteins Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here